Stay updated on Pimavanserin Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision history now includes v3.5.2 and removes v3.5.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedAdded a new record version v3.5.0 to the history; the previous v3.4.3 entry was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision v3.4.3 added to the history; revision v3.4.2 removed.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.2 was added to the history and an outdated funding notice was removed; these are minor site maintenance updates that do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check83 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operating status was added. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check91 days agoChange DetectedUI changes include a glossary toggle and color-coded marks for additions and deletions, with the revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.